AFP gene-modified dendritic cells induced immune response against human hepatocellular carcinomaHepG2 cells
刘扬,王跃如,丁光辉,杨庭松,姚乐,钱明平,张柏和,吴孟超,Lisa H. Butterfield
DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2015.07.015
2015-01-01
Abstract:Objective To investigate the immunoreactivity of the recombinant AFP-specific T cells in hepatocellular carcinoma in vitro and explore its potential mechanism.Methods To isolate and identify dendritic cells (DC),AFP adenovirus were constructed and transfected into DC to activate CD8 + T cells.There were 5 groups based on different treatments:HepG2 control Group,CD8 + T mock Group,CD8 + T Ad-AFP/DCs Group,CD8+ T mock + JAK2 inhibitor Group,and CD8+ T Ad-AFP/DCs + JAK2 inhibitor Group.To detect the cytotoxic effect of CD8 + T cells on HepG2 cells,CCK-8 assay was used to detect cell proliferation,and cell cycle and apoptosis were examined by flow cytometry.The expression of IL-2,IL-6,IL-6,IL-10,IFN-γ,TNF-α,perforin (PFP) and granzyme B were tested by ELISA assay,and western blot was used to detect the protein expression of p-STAT3/STAT3,p-JAK2/JAK2,Bax/Bcl-2 and Fas/Fasl.Results The results showed that CD8 + T cells can inhibit the proliferation of HepG2 cells,up-regulate the expression level of IL-2,IFN-γ,TNF-α,PFP,granzyme B and Bax/Bcl-2,but significantly inhibit expression of T cell activation negative regulator as IL-10,p-STAT3/STAT3 and p-JAK2/JAK2.Conclusions The activated AFP-specific T cells can dramatically suppress the proliferation of hepatocellular carcinoma,possibly by increasing Bax/bcl-2,promoting perforin/granzyme pathway and specifically killing HepG2.Besides,JAK2 inhibitors may play a regulatory role in the process.